Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc as Adjuvant Therapy in Severe Pneumonia
NCT00252304Phase 3Completed
- Sponsor
- Centre for International Health
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pneumonia comparing Zinc with Placebo (2 arms). Primary endpoints: Time to cessation of severe pneumonia and The period starting from enrolment to the beginning of a 24-hour consecutive period of absence of lower chest indrawing, of hypoxia and of any danger signs. Started Jan 2006; status: completed.
02
Drugs
zinc
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT00252304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252304.